Rebate Agreement for Allergen Extracts (Oralair)

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Oct 03, 2027 · 400 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Structured notice only

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Allergenextrakte aus Gräserpollen zur sublingualen Anwendung, Handelsbezeichnung Oralair(R), ATC V01AA02

70/100

Score d'opportunité

PromisingLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

70 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or volume is disclosed; it is unclear what rebate levels are expected or what volumes are covered.

Agreement can be superseded by a subsequent competitive discount contract for the same active ingredient, reducing the...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Strong opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until Nov 2027
Conclusion of non-exclusive rebate agreements for the pharmaceutical product Oralair(R) (allergen extracts from grass pollen for sublingual use).
Contract terms are pre-defined; no individual negotiation.

Afficher le résumé complet

This is an open-house model (not a competitive tender) by AOK Bayern for non-exclusive rebate agreements on the allergen extract Oralair(R) (ATC V01AA02). Any eligible pharmaceutical company can join. The contract runs from December 2025 to November 2027. Submission is rolling with monthly deadlines for contract start.

Risques

No estimated value or volume is disclosed; it is unclear what rebate levels are expected or what volumes are covered.

Agreement can be superseded by a subsequent competitive discount contract for the same active ingredient, reducing the...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

Only pharmaceutical companies (pharmazeutische Unternehmen) may participate.

Administrative

Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
Contract and appendix must be signed and submitted in duplicate if by paper, or with qualified electronic signature.

Les exigences peuvent être incomplètes.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Rebate Agreement for Allergen Extracts (Oralair)

Open-house rebate agreements for the specific product Oralair(R) (grass pollen allergen extracts for sublingual use, ATC V01AA02). Non-exclusive, identical terms for all participants.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Nov 2025 - Nov 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Oct 03, 2027

Détails de la procédure

Date de publication: 13 Oct 2025
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 674661-2025

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3